Bolt Biotherapeutics (BOLT) Prepaid Assets (2020 - 2026)
Bolt Biotherapeutics (BOLT) posted Prepaid Assets of $2.7 million for Q1 2026, up 4.11% sequentially from $2.6 million in Q4 2025, and down 7.86% YoY from $2.9 million in Q1 2025.
Bolt Biotherapeutics (BOLT) Prepaid Assets (2020 - 2026) Analysis & Trends
Bolt Biotherapeutics has reported Prepaid Assets for 7 years, with the latest figure at $2.7 million in Q1 2026.
- Quarterly Prepaid Assets fell 7.86% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.7 million (down 7.86% YoY) and the FY2025 annual result came in at $2.6 million, up 380.26% from the prior year.
- Prepaid Assets improved to $2.7 million in Q1 2026 per BOLT's latest filing, from $2.6 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $5.7 million in Q3 2023 and troughed at $532000.0 in Q4 2024.
- A 5-year average of $3.6 million and a median of $3.5 million in 2023 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2024 and 2025: Prepaid Assets sank 84.88% in 2024, then jumped 380.26% in 2025.
- Over 5 years, Prepaid Assets stood at $3.9 million in 2022, then fell by 8.79% to $3.5 million in 2023, then tumbled by 84.88% to $532000.0 in 2024, then soared by 380.26% to $2.6 million in 2025, then climbed by 4.11% to $2.7 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $2.7 million, $2.6 million, and $2.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Bolt Biotherapeutics | 6.10 Mn | 6.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.77 Mn |
| Mar 31, 2026 | 2.66 Mn |
| Dec 31, 2025 | 2.56 Mn |
| Sep 30, 2025 | 2.91 Mn |
| Jun 30, 2025 | 2.78 Mn |
| Mar 31, 2025 | 2.89 Mn |
| Dec 31, 2024 | 532,000.00 |
| Sep 30, 2024 | 2.56 Mn |
| Jun 30, 2024 | 2.93 Mn |
| Mar 31, 2024 | 3.71 Mn |
| Dec 31, 2023 | 3.52 Mn |
| Sep 30, 2023 | 5.74 Mn |
| Jun 30, 2023 | 4.80 Mn |
| Mar 31, 2023 | 5.23 Mn |
| Dec 31, 2022 | 3.86 Mn |
| Sep 30, 2022 | 3.70 Mn |
| Jun 30, 2022 | 4.93 Mn |
| Mar 31, 2022 | 5.19 Mn |
| Dec 31, 2021 | 2.94 Mn |
| Sep 30, 2021 | 9.60 Mn |